Larry I. Lipshultz, MD, discusses the frequency of renal failure and kidney transplants, as well as fertility and hormone differences in patients pre- and post-renal transplant. He then reviews drugs used to prevent organ rejection and the potential impact these drugs can have on offspring.
Read More
Maxx Gallegos, MD, reviews traditional urethral stricture management techniques, specifically direct visualization internal urethrotomy (DVIU) and dilation. He then discusses new and emerging techniques, especially urethroplasty, that may better benefit these patients.
Read More
Seth P. Lerner, MD, provides a brief overview of variant histologies in muscle invasive bladder cancer (MIBC). He then reviews individualized management options and optimal decision-making for treating the disease using three unique cases.
Read More Guilherme Godoy, MD, MPH, provides a brief overview of the pathogenesis and epidemiology of upper tract urothelial carcinoma (UTUC). He then reviews genomic classification, diagnosing and staging, current oncological principles of surgical therapy, and new risk-adapted treatment options for the disease.
Read More Ted Schenberg, CEO of Strand Diagnostics, explains how the DNA Specimen Provenance Assay minimizes adverse effects in cancer patients due to specimen provenance complications (SPCs) in biopsy reporting. He also discusses the UroSeq™ hereditary prostate cancer panel test, which Strand Diagnostics introduced earlier this year.
Read More